Arnd Kaltofen-Ehmann - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Arnd Kaltofen-Ehmann’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Hospitals,
- Drug Discovery,
- Wellness,
- Enterprise Software,
- Cryptocurrency,
- CRM,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Banking,
- Artificial Intelligence (AI),
- Robotics,
- Startups,
- Tech,
- Information Technology (IT),
- Diabetes,
- Technology,
- Finance,
- Software,
- Biotechnology,
- Medical Devices,
- Innovation,
- FinTech,
- Digital Transformation,
- Consumer Software,
- Logistics,
- UK Startups,
- Health Diagnostics,
- Digital Health,
- Medical,
- SaaS,
- Big Data,
- Information Technology,
- B2B,
- Therapeutics,
- Machine Learning,
- Pharmaceuticals,
- Healthcare Technology
Social media:
Past investments:
- HighLife
- Activaero
- L.E.S.S.
- ESBATech
- XO Life
- MerLion Pharma
- Endoart
- SilentSoft
- Ledgy
- SMART VALOR
- Equippo.com
- Genkyotex
- Sequana Medical
- Xeltis
- Windeln.de
- NemeriX
- iOnctura
- Endosense
- Oculis S.A.
- Visonys
- Pay by Shopping (deal united)
- SmallRivers
- Vara
- Advanon
- MESA Imaging
- CeQur
- Ganymed Pharmaceuticals
- Sonic Emotion AG
- Edimer Pharmaceuticals
- Mobileye, an Intel Company
- Neocutis
- Inositec
- Medlumics
- Gamaya
- Kuros Biosciences
- Covalys Biosciences
- JenaValve Technology
- Avalon Photonics
- Amal Therapeutics
- Spinelab
- Araris Biotech
- Flytrex
- UniKey Technologies
- Altoida
- Lambda Health System
- Nexthink
- Xigen
- PicoDRILL
- Delenex Therapeutics
Investor Profile
Arnd Kaltofen-Ehmann is a Venture Capital, Private Equity Firm based in Switzerland with a diverse investment portfolio that includes companies such as HighLife, Activaero, L.E.S.S., ESBATech, XO Life, MerLion Pharma, Endoart, SilentSoft, Ledgy, SMART VALOR, Equippo.com, Genkyotex, Sequana Medical, Xeltis, Windeln.de, NemeriXiOnctura, Endosense, Oculis S.A., Visonys, Pay by Shopping (deal united), SmallRivers, Vara, Advanon, MESA Imaging, CeQur, Ganymed Pharmaceuticals, Sonic Emotion AG, Edimer Pharmaceuticals, Mobileye, an Intel Company, Neocutis, Inositec, Medlumics, Gamaya, Kuros Biosciences, Covalys Biosciences, JenaValve Technology, Avalon Photonics, Amal Therapeutics, Spinelab, Araris Biotech, Flytrex, UniKey Technologies, Altoida, Lambda Health System, Nexthink, Xigen, PicoDRILL, Delenex Therapeutics, . Over time, Arnd Kaltofen-Ehmann has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Arnd Kaltofen-Ehmann is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Drug Discovery, Wellness, Enterprise Software, Cryptocurrency, CRM, Life Science, Portfolio Management, Medical Technologies, Banking, Artificial Intelligence (AI), Robotics, Startups, Tech, Information Technology (IT), Diabetes, Technology, Finance, Software, Biotechnology, Medical Devices, Innovation, FinTech, Digital Transformation, Consumer Software, Logistics, UK Startups, Health Diagnostics, Digital Health, Medical, SaaS, Big Data, Information Technology, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Arnd Kaltofen-Ehmann, as their portfolio suggests a familiarity and interest in this area.
Understanding Arnd Kaltofen-Ehmann’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
